N
NNG
vs
W
WIG20
Over the past 12 months, NNG has underperformed WIG20, delivering a return of -21% compared to the WIG20's +20% growth.
Stocks Performance
NNG vs WIG20
Performance By Year
NNG vs WIG20
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Nanogroup SA
Glance View
NanoGroup SA engages in the medical research and development. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2017-12-21. The firm focuses on the investment in, as well as development of advanced biotechnological projects in the areas of cancer prevention, early diagnosis, targeted cancer therapies and ontological rehabilitation. Its projects portfolio includes NanoVelos, which is responsible for the creation of drug delivery system for proven oncologic medicines to optimize their performance; NanoSanguis, which develops artificial blood to keep alive patients wounded in accidents, as well as a system, named Organ farm, to preserve human organs ex vivo, and NanoThea, which is dedicated to technology that detects cancer cells in early stage.
